CSE:AIAI - Post Discussion
Post by
yopmemama021 on Feb 28, 2022 4:48pm
MEND
wrapping up a solid month for $MEND.c $MNNDF
they partnered up with Cyclica to develop novel drugs for neurodegenerative diseases and had George Achilleos take over as CEO.
they launched their game changing AI technology, Netraplacebo, which will transform clinical trial success rates in the US$94B CNS therapeutics Market. $MEND ’s AI can create accurate hypotheses in less than an hour, about diseases that have taken years for pharmaceutical companies to discover
hoping soon with enough volume to see some price action start to reflect these major advancements
$MEND.c steady @$0.68 ,tight share structure with only 40 M OS
Be the first to comment on this post